Showing results (681-690 of 1,517) with videos related to
Sort By:
Pageof 152
Alzheimer Disease and Associated Disorders|December 14, 2011
Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging StudyMindy J Katz, Richard B Lipton, Charles B Hall, et al.Journal of Neuropathology and Experimental Neurology|November 1, 1995
Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165P Piccardo, B Ghetti, D W Dickson, et al.Biorxiv : the Preprint Server for Biology|June 25, 2024
Chromogranin A (CgA) Deficiency Attenuates Tauopathy by Altering Epinephrine-Alpha-Adrenergic Receptor SignalingSuborno Jati, Daniel Munoz-Mayorga, Shandy Shahabi, et al.Journal of Neuropathology and Experimental Neurology|November 14, 2012
A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathologyMelissa E Murray, Prashanthi Vemuri, Greg M Preboske, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 13, 2009
Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesiaEmmanuel Planel, Alexis Bretteville, Li Liu, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 7, 2020
Association of Tripartite Motif Containing 11 rs564309 With Tau Pathology in Progressive Supranuclear PalsyRebecca R Valentino, Shunsuke Koga, Michael G Heckman, et al.Journal of Neuropathology and Experimental Neurology|August 10, 2017
Perry Syndrome: A Distinctive Type of TDP-43 ProteinopathyTakayasu Mishima, Shunsuke Koga, Wen-Lang Lin, et al.Acta Neuropathologica|November 19, 2013
Staging TDP-43 pathology in Alzheimer's diseaseKeith A Josephs, Melissa E Murray, Jennifer L Whitwell, et al.Nature Communications|May 20, 2025
Chromogranin A deficiency attenuates tauopathy by altering epinephrine-alpha-adrenergic receptor signaling in PS19 miceSuborno Jati, Daniel Munoz-Mayorga, Shandy Shahabi, et al.Neuropathology and Applied Neurobiology|January 18, 2006
Lrrk2 R1441 substitution and progressive supranuclear palsyO A Ross, A J Whittle, S A Cobb, et al.Pageof 152